AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,024.00p
   
  • Change Today:
      36.00p
  • 52 Week High: 12,488.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 3,697,512
  • Market Cap: £186,399m
  • RiskGrade: 123

ShareCast News

London close: Stocks finish lower as wage growth... 16-Jan-2024 ShareCast
UBS downgrades AstraZeneca to 'sell' 16-Jan-2024 ShareCast
London close: Stocks fall amid rising geopolitic... 03-Jan-2024 ShareCast
Jefferies upgrades GSK to 'buy', cuts AstraZenec... 03-Jan-2024 ShareCast
London close: Stocks maintain gains amid post-Ch... 27-Dec-2023 ShareCast
London midday: Stocks ride global wave of post-C... 27-Dec-2023 ShareCast
London open: FTSE takes cues from Wall Street 'S... 27-Dec-2023 ShareCast
AstraZeneca to buy Gracell Technologies for $1.2bn 27-Dec-2023 ShareCast
AstraZeneca gets FDA green light for nerve disea... 22-Dec-2023 ShareCast
London close: Stocks slip as investors digest US... 12-Dec-2023 ShareCast
London midday: FTSE still firmer ahead of US inf... 12-Dec-2023 ShareCast
AstraZeneca to buy US vaccine maker Icosavax for... 12-Dec-2023 ShareCast
AstraZeneca calls off two phase III trials into ... 01-Dec-2023 ShareCast
London close: Stocks start week in subdued state 27-Nov-2023 ShareCast
London close: Stocks higher despite weaker retai... 17-Nov-2023 ShareCast
AstraZeneca gets US approval for breast cancer t... 17-Nov-2023 ShareCast
AstraZeneca's latest lung cancer trial fails its... 14-Nov-2023 ShareCast
London close: Stocks gain as investors await Pow... 09-Nov-2023 ShareCast
AstraZeneca hikes guidance after strong third qu... 09-Nov-2023 ShareCast
AstraZeneca invests $220m in French gene-editing... 01-Nov-2023 ShareCast
AstraZeneca agrees to settle most Nexium, Prilos... 03-Oct-2023 ShareCast
AstraZeneca reports positive findings from breas... 22-Sep-2023 ShareCast
AstraZeneca working with FDA on finer details of... 06-Sep-2023 ShareCast
AstraZeneca posts strong first half despite Covi... 28-Jul-2023 ShareCast
AstraZeneca, Sanofi infant respiratory treatment... 18-Jul-2023 ShareCast
AstraZeneca reveals mixed interim findings in lu... 03-Jul-2023 ShareCast
AstraZeneca planning spinoff of China business -... 19-Jun-2023 ShareCast
AstraZeneca gets new FDA RSV approval, partners ... 09-Jun-2023 ShareCast
AstraZeneca gets another US approval for Lynparza 01-Jun-2023 ShareCast
AstraZeneca's Imfinzi shows positive results for... 26-May-2023 ShareCast
AstraZeneca reports positive results in latest l... 17-May-2023 ShareCast
Director dealings: AstraZeneca CFO makes $1.5m s... 09-May-2023 ShareCast
AstraZeneca's Farxiga heart failure drug gets ex... 09-May-2023 ShareCast
Director dealings: Genus announces new CEO's com... 02-May-2023 ShareCast
AstraZeneca 'disappointed' with FDA panel vote o... 02-May-2023 ShareCast
AstraZeneca beats Q1 estimates 27-Apr-2023 ShareCast
AstraZeneca inks simpler deal for nirsevimab in US 11-Apr-2023 ShareCast
AstraZeneca reports positive analysis from ovari... 05-Apr-2023 ShareCast
AstraZeneca drug recommended for EU marketing au... 03-Apr-2023 ShareCast
AstraZeneca's Imfinzi trial shows 'significantly... 09-Mar-2023 ShareCast
AstraZeneca, Daiichi's Enhertu hits trial targets 06-Mar-2023 ShareCast
AstraZeneca, KYM sign licensing deal on gastric ... 23-Feb-2023 ShareCast
AstraZeneca FY core EPS in line; Aims for growth... 09-Feb-2023 ShareCast
Sector movers: Miners and Big Pharma drag 01-Feb-2023 ShareCast
AstraZeneca to buy US-based CinCor in $1.8bn deal 09-Jan-2023 ShareCast
AstraZeneca gets new approvals in Japan on three... 28-Dec-2022 ShareCast
AstraZeneca's Imfinzi plus Imjudo recommended fo... 19-Dec-2022 ShareCast
AstraZeneca's Forziga recommended for EU use 19-Dec-2022 ShareCast
FDA gives AstraZeneca extension on cancer drug a... 15-Dec-2022 ShareCast
AstraZeneca hails positive findings in breast ca... 08-Dec-2022 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 12,024.00p
Change Today 36.00p
% Change 0.30 %
52 Week High 12,488.00
52 Week Low 9,501.00
Volume 3,697,512
Shares Issued 1,550.22m
Market Cap £186,399m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average91.68% below the market average
92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average92.16% below the sector average
Price Trend
57.75% above the market average57.75% above the market average57.75% above the market average57.75% above the market average57.75% above the market average
82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average82.14% above the sector average
Income
87.48% below the market average87.48% below the market average87.48% below the market average87.48% below the market average87.48% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

What The Brokers Say

Strong Buy 8
Buy 15
Neutral 5
Sell 0
Strong Sell 1
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 29-Apr-2024

Time Volume / Share Price
09:00 500 @ 12,086.00p
09:23 500 @ 12,080.00p
16:17 0 @ 12,030.00p
16:20 0 @ 12,028.00p
16:16 0 @ 12,022.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page